TRNAU1AP
tRNA selenocysteine 1-associated protein 1
Also known as: FLJ20503, SECP43, TRSPAP1, TSAP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NX07
- Gene
- TRNAU1AP
- Ensembl
- ENSG00000180098
- Chromosome
- 1
- Canonical length
- 287 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in selenocysteine incorporation. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>Q9NX07|TRNAU1AP
1 MAASLWMGDL EPYMDENFIS RAFATMGETV MSVKIIRNRL TGIPAGYCFV EFADLATAEK
61 CLHKINGKPL PGATPAKRFK LNYATYGKQP DNSPEYSLFV GDLTPDVDDG MLYEFFVKVY
121 PSCRGGKVVL DQTGVSKGYG FVKFTDELEQ KRALTECQGA VGLGSKPVRL SVAIPKASRV
181 KPVEYSQMYS YSYNQYYQQY QNYYAQWGYD QNTGSYSYSY PQYGYTQSTM QTYEEVGDDA
241 LEDPMPQLDV TEANKEFMEQ SEELYDALMD CHWQPLDTVS SEIPAMMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRNAU1AP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 8.7 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 8.7 nTPM
- thymus: 7.9 nTPM
- choroid plexus: 7.1 nTPM
- retina: 6.7 nTPM
- skin: 6.5 nTPM
- tonsil: 6.5 nTPM
Single-cell type
- esophageal apical cells: 124 nCPM
- syncytiotrophoblasts: 120 nCPM
- respiratory ciliated cells: 95 nCPM
- urothelial cells: 86 nCPM
- myonuclei: 78 nCPM
- extravillous trophoblasts: 78 nCPM
Immune cell
- NK-cell: 9.8 nTPM
- eosinophil: 7.3 nTPM
- basophil: 5.4 nTPM
- naive CD4 T-cell: 5.4 nTPM
- memory CD8 T-cell: 5.3 nTPM
- intermediate monocyte: 4.5 nTPM
Brain region
- cerebellum: 9.7 nTPM
- white matter: 7.6 nTPM
- medulla oblongata: 6.5 nTPM
- hypothalamus: 6.4 nTPM
- basal ganglia: 6.3 nTPM
- pons: 6.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- tRNA selenocysteine 1-associated protein 1
- tRNA selenocysteine 1-associated protein 1, C-terminal
- RNA recognition motif
- Selenocysteine tRNA 1 associated proteins
- SECp43, RNA recognition motif 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRNAU1AP as an antibody target. Whether an autoantibody or antibody against TRNAU1AP could matter depends on whether native TRNAU1AP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRNAU1AP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRNAU1AP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...